Sarepta Therapeutics (SRPT) EBT Margin (2010 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly EBT Margin of 46.96% for Q1 2026, up 33460.0% year-over-year from N/an in Q1 2025, and up 174.74% quarter-over-quarter from 62.83% in Q4 2025.
Sarepta Therapeutics (SRPT) EBT Margin (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' EBT Margin history runs 15 years deep, the most recent figure standing at 46.96% for Q1 2026.
- In Q1 2026, EBT Margin rose 33460.0% year-over-year to 46.96%; the TTM figure through Mar 2026 stood at 1.12% (up 1124.0% YoY), while the FY2025 annual figure was 37.67%, down 5138.0% from the prior year.
- EBT Margin for Q1 2026 stood at 46.96%, up from 62.83% in the prior quarter.
- The five-year high for EBT Margin was 46.96% in Q1 2026, with the low at 287.64% in Q1 2025.
- The 5-year median for EBT Margin is 5.58% (2023), against an average of 44.08%.
- The sharpest annual moves came in 2025 and 2026: EBT Margin slumped 29766 bps in 2025, then soared 33460 bps in 2026.
- Sarepta Therapeutics' EBT Margin stood at 38.93% in 2022, then plunged by 90 bps to 3.74% in 2023, then soared by 597 bps to 26.08% in 2024, then sank by 341 bps to 62.83% in 2025, then surged by 175 bps to 46.96% in 2026.
- Business Quant data shows SRPT's EBT Margin at 46.96% in Q1 2026, 62.83% in Q4 2025, and 48.59% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | -0.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.44% |
| Mar 31, 2026 | 46.96% |
| Dec 31, 2025 | -62.83% |
| Sep 30, 2025 | -48.59% |
| Jun 30, 2025 | 25.14% |
| Mar 31, 2025 | -287.64% |
| Dec 31, 2024 | 26.08% |
| Sep 30, 2024 | 7.28% |
| Jun 30, 2024 | 3.74% |
| Mar 31, 2024 | 10.02% |
| Dec 31, 2023 | 3.74% |
| Sep 30, 2023 | -10.72% |
| Jun 30, 2023 | -5.58% |
| Mar 31, 2023 | -221.48% |
| Dec 31, 2022 | 38.93% |
| Sep 30, 2022 | -111.36% |
| Jun 30, 2022 | -107.98% |
| Mar 31, 2022 | -55.16% |
| Dec 31, 2021 | -68.20% |
| Sep 30, 2021 | -212.97% |